Biden administration targets overuse of antipsychotic drugs in nursing homes

Published



The Biden administration is planning to investigate the inappropriate use of certain antipsychotic drugs and wrongful diagnoses of schizophrenia in nursing homes as part of an initiative to crack down on the misuse of medications that may cause dangerous side effects.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.